Literature DB >> 17125903

Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.

José H T G Fregnani1, Fernando A Soares, Pablo R Novik, Ademar Lopes, Maria R D O Latorre.   

Abstract

OBJECTIVES: (1) To compare the anatomopathological variables and recurrence rates in patients with early-stage adenocarcinoma (AC) and squamous cell carcinoma (SCC) of the uterine cervix; (2) to identify the independent risk factors for recurrence. STUDY
DESIGN: This historical cohort study assessed 238 patients with carcinoma of the uterine cervix (IB and IIA), who underwent radical hysterectomy with pelvic lymph node dissection between 1980 and 1999. Comparison of category variables between the two histological types was carried out using the Pearson's chi(2)-test or Fisher exact test. Disease-free survival rates for AC and SCC were calculated using the Kaplan-Meier method and the curves were compared using the log-rank test. The Cox proportional hazards model was used to identify the independent risk factors for recurrence.
RESULTS: There were 35 cases of AC (14.7%) and 203 of SCC (85.3%). AC presented lower histological grade than did SCC (grade 1: 68.6% versus 9.4%; p<0.001), lower rate of lymphovascular space involvement (25.7% versus 53.7%; p=0.002), lower rate of invasion into the middle or deep thirds of the uterine cervix (40.0% versus 80.8%; p<0.001) and lower rate of lymph node metastasis (2.9% versus 16.3%; p=0.036). Although the recurrence rate was lower for AC than for SCC (11.4% versus 15.8%), this difference was not statistically significant (p=0.509). Multivariate analysis identified three independent risk factors for recurrence: presence of metastases in the pelvic lymph nodes, invasion of the deep third of the uterine cervix and absence of or slight inflammatory reaction in the cervix. When these variables were adjusted for the histological type and radiotherapy status, they remained in the model as independent risk factors.
CONCLUSION: The AC group showed less aggressive histological behavior than did the SCC group, but no difference in the disease-free survival rates was noted.

Entities:  

Mesh:

Year:  2006        PMID: 17125903     DOI: 10.1016/j.ejogrb.2006.10.021

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  12 in total

1.  Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.

Authors:  Mariana Gamba De Paula Eduardo; Adriana Bittencourt Campaner; Maria Antonieta Longo Galvão Silva
Journal:  Pathol Oncol Res       Date:  2015-02-15       Impact factor: 3.201

2.  A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.

Authors:  Xiuzhen Xie; Kun Song; Baoxia Cui; Jie Jiang; Xingsheng Yang; Beihua Kong
Journal:  Int J Clin Oncol       Date:  2018-01-03       Impact factor: 3.402

3.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

4.  Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix.

Authors:  J-Y Park; D-Y Kim; J-H Kim; Y-M Kim; Y-T Kim; J-H Nam
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

5.  Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I-II cervical cancer.

Authors:  Makoto Yamauchi; Takeshi Fukuda; Takuma Wada; Masaru Kawanishi; Kenji Imai; Yasunori Hashiguchi; Tomoyuki Ichimura; Tomoyo Yasui; Toshiyuki Sumi
Journal:  Mol Clin Oncol       Date:  2014-05-15

6.  Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma.

Authors:  Suthida Intaraphet; Nongyao Kasatpibal; Mette Søgaard; Surapan Khunamornpong; Jayanton Patumanond; Anchalee Chandacham; Imjai Chitapanarux; Sumalee Siriaunkgul
Journal:  Onco Targets Ther       Date:  2014-07-01       Impact factor: 4.147

7.  Mesonephric adenocarcinoma of the cervix: Case report and literature review.

Authors:  A Dierickx; M Göker; G Braems; P Tummers; R Van den Broecke
Journal:  Gynecol Oncol Rep       Date:  2016-05-07

8.  Clinicopathologic and Molecular Characteristics of Mesonephric Adenocarcinoma Arising From the Uterine Body.

Authors:  Kiyong Na; Hyun-Soo Kim
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

9.  Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

Authors:  T Kasamatsu; T Onda; M Sawada; T Kato; S Ikeda; Y Sasajima; H Tsuda
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Tatsuya Kato; Hidemichi Watari; Mahito Takeda; Masayoshi Hosaka; Takashi Mitamura; Noriko Kobayashi; Satoko Sudo; Masanori Kaneuchi; Masataka Kudo; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.